BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76
15789 results:

  • 1. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
    Fu G; Chazen RS; MacMillan C; Witterick IJ
    JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Imaging characteristics and diagnosis of primary middle mediastinal tumors].
    Chen JQ; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):449-456. PubMed ID: 38742358
    [No Abstract]    [Full Text] [Related]  

  • 3. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
    Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
    BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity.
    Ballico M; Alessi D; Aneggi E; Busato M; Zuccaccia D; Allegri L; Damante G; Jandl C; Baratta W
    Molecules; 2024 May; 29(9):. PubMed ID: 38731639
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of the new molecular subtypes related to inflammation in breast cancer.
    Yu K; Xu C; Wang F; Wang H
    Medicine (Baltimore); 2024 May; 103(19):e38146. PubMed ID: 38728446
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
    Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
    Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessing the relative effectiveness of various ultrasound-guided ablation techniques for treating benign thyroid nodules: A systematic review and network meta-analysis.
    Sun X; Chen J; Zou Y; Lei J; Liu W
    Medicine (Baltimore); 2024 May; 103(18):e38014. PubMed ID: 38701262
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Score based on contrast-enhanced ultrasound predict central lymph node metastasis in papillary thyroid cancer.
    He L; Chen X; Hu J; Meng Y; Zhang Y; Chen W; Fan Y; Li T; Fang J
    Front Endocrinol (Lausanne); 2024; 15():1336787. PubMed ID: 38699389
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Feasibility and safety of modified en-bloc resection in endoscopic thyroid surgery via bilateral areolar approach - long-term institutional analysis ten years after surgery.
    Xie Q; Ma J; Du Y; Liu L; Zhu R; Liu D; Wang P; Yu X
    Front Endocrinol (Lausanne); 2024; 15():1302510. PubMed ID: 38694946
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
    Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
    World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
    Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
    Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
    Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
    Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
    Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnostic Value of Immunostaining for thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
    Ji N; Lee Y; Lee SH; Kim HS
    Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. New strategy for intraoperative phonosurgical management of recurrent laryngeal nerve infiltrated by thyroid carcinoma.
    Peng J; Zhu G; Gao Y; Song X; Yu H; Huang R; Chen M; Jiang Y; Sun G; Li M; Zheng H; Wang W
    Langenbecks Arch Surg; 2024 Apr; 409(1):138. PubMed ID: 38676783
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Assessment of thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
    Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
    Fugazzola L; Deandrea M; Borgato S; Dell'Acqua M; Retta F; Mormile A; Carzaniga C; Gazzano G; Pogliaghi G; Muzza M; Persani L
    Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657647
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 790.